<- Go home

Added to YB: 2023-08-18

Pitch date: 2023-08-18

ALPN [bullish]

Alpine Immune Sciences, Inc.

+409.97%

current return

Author Info

No bio for this author

Company Info

Alpine Immune Sciences, Inc. operates as a clinical-stage biopharmaceutical company. It focuses on the discovery and development of immunotherapies through protein engineering technologies for treating autoimmune and inflammatory diseases.

Market Cap

$4.5B

Pitch Price

$12.74

Price Target

N/A

Dividend

N/A

EV/EBITDA

-86.71

P/E

-95.45

EV/Sales

73.61

Sector

Biotechnology

Category

N/A

Show full summary:
ALPINE IMMUNE SCIENCES INC ALPN

A summary for this pitch has not been created yet.

Read full article (0 min)